HR | 95%CI | P | |
---|---|---|---|
Gender | |||
Female | 1 | ||
Male | 0.364 | 0.095–1.389 | 0.139 |
Age | |||
≤ 60 | 1 | ||
>60 | 0.885 | 0.248–3.156 | 0.851 |
Surgical approach | |||
Open surgery | 1 | ||
Laparoscopic surgery | 0.323 | 0.086–1.205 | 0.092 |
Type of surgery | |||
Partial nephrectomy | 1 | ||
Radical nephrectomy | 0.092 | 0.012–0.726 | 0.024 |
Cell-based immunotherapy | |||
No | 1 | ||
Yes | 1.132 | 0.236–5.425 | 0.877 |
Tumor stage | |||
T1/T2 | 1 | ||
T3/T4 | 12.136 | 2.557–57.599 | 0.002 |
WHO/ISUP grade | |||
G1/G2 | 1 | ||
G3/G4 | 13.692 | 2.890–64.874 | 0.001 |
PRCC subtype | |||
type 1 | 1 | ||
type 2 | 8.326 | 1.050–66.024 | 0.045 |
Tumor size | 1.340 | 1.117–1.608 | 0.002 |